
Netflix’s Earnings Rebound, Surveying the Airline Stocks, and BioMarin CEO 10/19/22
Mad Money w/ Jim Cramer
00:00
The Future of Cardiomyopathy Hypertrophic Parvial Marketing
We are shooting for filing an IND which is allowing us to start human clinical trials in about a year or so from now. This will be the biggest indication for which the gene therapy is going to be attempted we're talking hundreds of thousands of patients potentially with a huge unmet need. We are super excited about this uh celery early but our pre-critical data and our human individual data of myocytes is very exciting. Well many people promise in drugs I tend not to even let them go on but your record on this show of what you can deliver is extraordinary, JJ.
Transcript
Play full episode